Quintiles GmbH and Cerner Corporation Work Together to Improve Efficiency of Late Phase Research Studies

RESEARCH TRIANGLE PARK, N.C. & KANSAS CITY, Mo.--(BUSINESS WIRE)--Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, and Cerner, a global supplier of healthcare solutions and electronic health record (EHR) technology, today announced an agreement that will provide biopharma sponsors with research and technology services to help them quickly evaluate the benefits and side effects of therapeutic treatments currently on the market.

MORE ON THIS TOPIC